Publications

Inivata actively publishes and presents new data. Please find a full listing below by year.

Featured Publication

Clinical utility of ctDNA genomic alterations (GA) based on ESMO scale for clinical actionability of molecular targets (ESCAT) in advanced NSCLC

Event name - ESMO Asia 2019

L. Mezquita, D. Planchard, M. Dorta, M. Aldea, C. Naltet, V. Lamberts, M. Grecea, P. Martin-Romano, F. de Kievit, C. Jovelet, E. Rouleau, L. Lacroix, J. Remon, P. Lavaud, A. Gazzah, C. Morris, K. Howarth, E. Green, G. Vassal, C. Massard and B. Besse Read More

Clinical Utility of ctDNA Driver Genomic Alterations (GA) Directing Targeted Therapy in Untreated Advanced NSCLC Patients

Event name - North America Conference on Lung Cancer 2019

L. Mezquita, D. Planchard, M. Dorta, M. Aldea, C. Naltet, V. Lamberts, A.-M. Grecea, P. Martin-Romano, F. de Kievit, C. Jovelet, E. Rouleau, L. Lacroix, J. Remon, P. Lavaud, A. Gazzah, C. Morris, K. Howarth, E. Green, C. Massard, B. Besse Read More

Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer

Event name - Clinical Cancer Research 2019

Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z Rizvi, Rosa L Frias, Jean Paul Thiery, Jean-Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Deas, Dariia Samofalova, Justine Galissant, Pauline Tesson, FlorianeBraye, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, ClaudioNicotra, Maud Ngo-Camus, Stefan […] Read More

Circulating tumor DNA analysis reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant non-small cell lung cancer

Event name - ESMO 2019

Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazières, Cecile Jovelet, Washington René Chumbi Flores, Ludovic Lacroix, Yohan Loriot, Luc Friboulet, Virginie Westeel, Maud Ngocamus, Anne Pradines, Claire Tissot, Christelle Clement Duchene, Christine Raynaud, Xavier Quantin, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Virginie Avrillon, Céline Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank de […] Read More

Improved ctDNA detection in early stage non-small cell lung cancer

Event name - CNAPS 2019

Katrin Heider, Jonathan CM Wan, Davina Gale, Andrea Ruiz-Valdepenas, Florent Mouliere, James Morris, Wendi Qian, Jerome Wulff, Nikolaos Demiris, Karen Howarth, Emma Green, Alexandra Williams, Tim Eisen, Christopher G Smith, Doris M. Rassl, Susan Harden, Robert C. Rintoul, Charles Massie, Nitzan Rosenfeld Read More

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer

Event name - Lung Cancer Journal 2019

Nicolas Guibert, Greg Jones, John F. Beeler, Vincent Plagnol, Clive Morris, Jean Mourlanette, Myriam Delaunay, Laura Keller, Isabelle Rouquette, Gilles Favre, Anne Pradines, Julien Mazieres Read More

Circulating tumor DNA assay and survival in patients with metastatic, non-small cell lung cancer

Event name - WCLC 2019

Jennifer L. Ersek, Madeline Hosking, James Symanowski, Qing Zhang, Emma Green, Edward S. Kim Read More

Longitudinal circulating tumor DNA analysis in blood and saliva predicts response to osimertinib and disease progression in EGFR-mutant non-small-cell lung cancer

Event name - WCLC 2019

Chul Kim, Liqiang Xi, Constance M. Cultraro, Fang Wei, Gregory Jones, Jordan Cheng, Ahmad Shafiei, Trinh Hoc-Tran Pham, Nitin Roper, Elizabeth Akoth, Vikram Misra, Nina Monkash, Charles Strom, Michael Tu, Wei Liao, David Chia, Clive Morris, Seth M. Steinberg, Mohammadhadi Bagheri, David T.W. Wong, Mark Raffeld, Udayan Guha. Read More

Circulating tumor DNA (ctDNA) analysis for genomic testing in non small cell lung cancer (NSCLC) patients with isolated central nervous system progression (iCNS)

Event name - ASCO 2019

Mihaela Aldea, Laura Mezquita, Lizza Hendriks, Edouard Auclin, Jordi Remon, David Planchard, Cécile Jovelet, Jose Carlos Benitez, Anas Gazzah, Pernelle Lavaud, Charles Naltet, Ludovic Lacroix, Clive Morris, Emma Green, Karen Howarth, Claudio Nicotra and Benjamin Besse Read More

Efficacy of TKIs based on the ALK resistance mutations on amplicon-based liquid biopsy in ALK positive Non-Small Cell Lung Cancer (NSCLC) patients

Event name - ASCO 2019

L Mezquita, A Swalduz, C Jovelet, S Ortiz-Cuaran, D Planchard, G Recondo, JC Benitez, K Howarth, F de Kievit, C Morris, E Green, L Lacroix, L Odier, E Rouleau, P Fournel, C Caramella, C Tissot, C Nicotra, M Pérol, C Massard, L Friboulet, B Besse, P Saintigny Read More

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer

Event name - Advances in Radiation Oncology

Michael N.Corradetti MD, PhD;  Jordan A. Torok MD; Ace J.Hatch PhD; Eric P.Xanthopoulos MD; JD Kyle Lafata PhD; Corbin Jacobs MD; Christel Rushing MA; John Calaway PhD; Greg Jones MS; Chris R.Kelsey MD; Andrew B.Nixon PhD Read More

Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer

Event name - JCO Precis Oncol. 2019

Michael A. Pritchett, D. Ross Camidge, Manu Patel, Jamil Khatri, Steven Boniol, Elke K. Friedman, Abderrahim Khomani, Samir Dalia, Katherine Baker-Neblett, Vincent Plagnol, Karen D. Howarth, Gregory R. Jones; Nitzan Rosenfeld, Clive D. Morris and Ramaswamy Govindan. Read More

Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non–Small-Cell Lung Cancer

Event name - JCO Precis Oncol. 2019

Jordi Remon; Ludovic Lacroix; Cecile Jovelet, Caroline Caramella, Karen Howarth, ; Vincent Plagnol, Nitzan Rosenfeld, Clive Morris, Laura Mezquita, Chloe Pannet; Maud Ngocamus; Cecile Le Pechoux, Julien Adam, Alina-Miruna Grecea, David Planchard, Gilles Vassal, Jose Carlos Benitez, Anas Gazzah, Emma Green; Jean-Charles Soria, and Benjamin Besse. Read More

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced NSCLC

Event name - SITC/ASCO2019

Nicolas Guibert MD, Greg Jones, John Beeler PhD, Vincent Plagnol PhD, Jean Mourlanette, Myriam Delaunay MD, Anne Casanova, Gilles Favre PhD, Anne Pradines PhD and Julien Mazieres MD PhD Read More

ctDNA: A Novel Biomarker for Immunotherapy Response in Advanced Lung Cancer

Event name - SITC 2018

Meera Yogarajah, Ebenezer Ofori Appah, Katherine Baker Neblett, Clive D. Morris, Greg Jones, Vincent Plagnol and Paul R. Walker     Read More

Early plasma ctDNA response anticipates clinical response to first-line immunotherapy in advanced NSCLC

Event name - WCLC 2018

Mark M. Awad, Biagio Ricciuti, Christine A. Lydon, Anika Adeni, Safiya Subegdjo, Greg Jones, Vincent Plagnol, John Beeler and Geoffrey R. Oxnard     Read More

Prospective clinical validation of the InVisionFirst™ ctDNA assay for molecular profiling of patients with advanced NSCLC

Event name - WCLC 2018

Ramaswamy Govindan, Michael A. Pritchett, D. Ross Camidge, Manu Patel, Jamil Khatri, Steven Boniol, Elke K. Friedman, Abderrahim Khomani, Samir Dalia, Katherine Baker-Neblett, Vincent Plagnol, Karen Howarth, Nitzan Rosenfeld and Clive D. Morris     Read More

Feasibility, clinical relevance of ALK/ROS1 fusion variant detection by liquid biopsy in advanced non-small cell lung cancer

Event name - WCLC2018

Aurélie Swalduz, Laura Mezquita, Sandra Ortiz-Cuaran, Cécile Jovelet, Virginie Avrillon, David Planchard, Solène Marteau, Gonzalo Recondo, Séverine Martinez, Frank De Kievit, Vincent Plagnol, Karen Howarth, Clive Morris, Emma Green, Luc Odier, Ludovic Lacroix, Pierre Fournel, Etienne Rouleau, Claire Tissot, Caroline Caramella, Stéphane Hominal, Luc Friboulet, Maurice Pérol, Benjamin Besse and Pierre Saintigny Read More

Prospective efficacy of osimertinib in circulating tumour DNA (ctDNA) T790M-mutant NSCLC patients

Event name - WCLC 2018

J.Remon, C. Jovelet, L. Lacroix, D. Planchard, L. Mezquita, K. Howarth,E. Green, V. Plagnol, C Morris, N Rosenfeld, C. Caramella, C. Le Péchoux C, F.Aboubakar Nana, E. Auclin, A. Botticella, J. Adam, R. Ferrara, A. Gazzah, M. Ngocamus, JC. Soria, B. Besse.     Read More

Validation of InVisionFirst ctDNA NGS profiling via ddPCR testing in patients with Non-Small cell lung cancer (NSCLC)

Event name - WCLC 2018

Michael A. Pritchett, Katherine Baker-Neblett, Kathryn Finch Mileham, Vincent Plagnol, Karen Howarth, Tim Forshew, Greg Jones, Clive Morris     Read More

Clinical relevance OF ALK/ROS1 resistance mutations and other acquired mutations detected by liquid biopsy in advanced NSCLC patients

Event name - WCLC 2018

L Mezquita, A Swalduz, C Jovelet, S Ortiz-Cuaran, David Planchard, V Avrillon, G Recondo, S Marteau, V Plagnol, K Howarth, C Morris, E Green, L Lacroix, L Odier, E Rouleau, P Fournel, C Caramella, C Tissot, Julien Adam, M Pérol, Luc Friboulet, Pierre Saintigny, B Besse     Read More

Circulating Tumor DNA Analysis for Predicting Response to Osimertinib and Disease Progression in EGFR-Mutant Non-Small-Cell Lung Cancer

Event name - WCLC 2018

Chul Kim, Liqiang Xi, Constance M. Cultraro , Trinh Hoc-Pham Tran, Ahmad Shafei, Nitin Roper, Mohammadhadi Bagheri, John Beeler, Gregory Jones , Mark Raffeld and Udayan Guha Read More

TIMELY: Multicentre phase II trial of first-line afatinib in patients with suspected/confirmed EGFR mutant NSCLC – ctDNA and long-term efficacy

Event name - WCLC2018

Sanjay Popat, Adam Januszewski, Laura Hughes, Mary O’Brien, Tanya Ahmad, Conrad Lewanski, Ulrike Dernedde, Petra Jankowska, Clive Mulatero, Riyaz Shah, Jonathan Hicks,Tom Geldart, Mathilda Cominos, Gill Gray, James Spicer, Karen Bell, Simon Roitt, Karen Howarth, Mattia Cinelli, Emma Green, Clive Morris, Yenting Ngai, Allan Hackshaw Read More

Clinical outcomes in patients with advanced NSCLC treated with targeted therapies, with actionable mutations identified by InVisionFirstctDNA assay

Event name - MAP 2018

Jordi Remon, Sandra Ortiz-Cuaran, Laura Mezquita, Aurelie Swalduz, Karen Howarth, Cecile Jovelet, Ludovic Lacroix, Etienne Rouleau, Frank De Kievit, Katherine Baker-Neblett, Simon Roitt, Vincent Plagnol, Clive Morris, Emma Green, Maurice Perol, David Planchard, Pierre Saintigny, Benjamin Besse Read More

An Amplicon-Based Liquid Biopsy For Detecting ALK and ROS1 Fusions And Resistance Mutations In Advances Non-Small Cell Lung Cancer (NSCLC) Patients

Event name - ASCO 2018

L Mezquita, C Jovelet, L Lacroix, D Planchard, G Recondo, E Pailler, E Auclin, V Plagnol, K Howarth, C Morris, E Green, E Rouleau, C Nicotra, C Caramella, J Adam, N Auger, F Farace, L Friboulet, B Besse Read More

Early prediction of outcomes to PD1 inhibitors in non-small cell lung cancer using next generation sequencing of plasma circulating tumor DNA

Event name - ASCO 2018

Nicolas Guibert, MD, Greg Jones, John Beeler, PhD, Vincent Plagnol, PhD, Jean Mourlanette, Myriam Delaunaya, Anne Casanova, Gilles Favre, PhD, Anne Pradines, PhD, Julien Mazieres, MD, PhD Read More

Longitudinal circulating-tumor DNA profiling of EGFR-mutated non-small cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors

Event name - AACR 2018 - Please contact us for more information on this poster

Sandra Ortiz-Cuaran, Aurélie Swalduz, Camille Léonce, Solène Marteau, Séverine Martinez, Gilles Clapisson, Virginie Avrillon, Luc Odier, Lionel Falchero, Pierre Fournel, Emma Green, Clive Morris, Maurice Pérol, Pierre Saintingy. Read More

Analytical validation of InVisionFirst™, a liquid biopsy assay for high-sensitivity broad molecular profiling of circulating tumor DNA using plasma samples of cancer patients

Event name - AACR 2018 - Please contact us for more information on this presentation

Samuel Woodhouse, Vincent Plagnol, Karen Howarth, Stefanie Lensing, Matt Smith, Michael Epstein, Mikidache Madi, Sarah Smalley, Catherine Leroy, Jonathan Hinton, Frank de Kievit, Esther Musgrave-Brown, Colin Herd, Katherine Baker-Neblett, Will Brennan, Peter Dimitrov, Nathan Campbell, Nitzan Rosenfeld, James Clark, Davina Gale, Jamie Platt, John Calawa2, Greg Jones and Tim Forshew Read More

Feasibility of an amplicon-based liquid biopsy assay for ALK and ROS1 gene fusions in advanced non-small cell lung cancer patients

Event name - AACR 2018

L Mezquita, Y Hu, K Howarth, C Jovelet, D Planchard, L Lacroix, A Swalduz, S Ortiz-Cuaran, V Avrillon, V Plagnol K Baker-Neblett, G Jones, N. Rosenfeld, C Morris, E Green, ES Kim, M Perol, P Saintigny, SV Liu, GR Oxnard, B Besse Read More

Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling

Event name - PLOS ONE 2018

Vincent Plagnol, Samuel Woodhouse, Karen Howarth, Stefanie Lensing, Matt Smith, Michael Epstein, Mikidache Madi, Sarah Smalley, Catherine Leroy, Jonathan Hinton, Frank de Kievit, Esther Musgrave-Brown, Colin Herd, Katherine Baker-Neblett, Will Brennan, Peter Dimitrov, Nathan Campbell, Clive Morris, Nitzan Rosenfeld, James Clark, Davina Gale, Jamie Platt, John Calaway, Greg Jones, Tim Forshew Read More

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA

Event name - PLOS ONE 2018

Davina Gale , Andrew R. J. Lawson, Karen Howarth, Mikidache Madi, Bradley Durham, Sarah Smalley, John Calaway, Shannon Blais, Greg Jones, James Clark, Peter Dimitrov, Michelle Pugh, Samuel Woodhouse, Michael Epstein, Ana Fernandez-Gonzalez, Alexandra S. Whale, Jim F. Huggett, Carole A. Foy, Gerwyn M. Jones, Hadas Raveh-Amit, Karin Schmitt, Alison Devonshire, Emma Green, Tim Forshew, […] Read More

Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer

Event name - Annals of Oncology 2018

Nicolas M. Guibert, Yuebi Hu, Nora Feeney, Vincent Plagnol, Greg Jones, Karen Howarth, John Beeler, Cloud P. Paweletz, Geoffrey R. Oxnard Read More

Evaluation of stored liquid biopsies for molecular profiling in non-small cell lung cancer (NSCLC) patients

Event name - ASCO 2017

Penelope A. Bradbury, Keyue Ding, Peter M. Ellis, Lesley Seymour, Frank De Kievit, Greg Jones, Clive Morris, Emma, Green, Glenwood D. Goss, Ming Sound Tsao, Frances A. Shepherd Read More

Liquid biopsies come of age: towards implementation of circulating tumour DNA

Event name - Nature Reviews Cancer 2017

Jonathan C. M. Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D. Brenton, Carlos Caldas, Simon Pacey, Richard Baird and Nitzan Rosenfeld Read More

Evaluation of liquid biopsies for molecular profiling in advanced non-small cell lung cancer (NSCLC) patients in the relapse treatment setting

Event name - ASCO 2017

Remon J, Besse B, Lacroix L, Mezquita L, Jovelet C, Howarth K, Plagnol V, Morris C, Nicotra C, Pannet C, Green E, Soria JC Read More

Comparison of enhanced Tagged-Amplicon Sequencing and digital PCR for circulating tumor DNA analysis in advanced breast cancer

Event name - AACR 2017

Isaac Garcia-Murillas, Matthew Beaney, Michael Epstein, Karen Howarth, Andrew Lawson, Sarah Hrebien, Emma Green, Nitzan Rosenfeld and Nicholas C. Turner Read More

Evaluation of liquid biopsies for molecular profiling in untreated advanced non-small cell lung cancer (NSCLC) patients

Event name - ASCO 2017

Besse B, Remon J, Lacroix L, Mezquita L, Jovelet C, Howarth K, Plagnol V, Morris C, Nicotra C, Pannet C, Green E, Soria JC. Read More

Amplicon-based next-generation sequencing (NGS) of plasma cell-free DNA (cfDNA) for detection of driver and resistance mutations in advanced NSCLC

Event name - WCLC 2017

Nicolas M. Guibert, Yuebi Hu, Nora Feeney, Michael Epstein, Samuel Woodhouse, Karen Howarth, Vincent Plagnol, John Beeler, Greg Jones, Cloud P. Paweletz, Geoffrey R. Oxnard Read More

Molecular profiling of advanced pancreatic cancer (PC) patients from a phase I/II study using circulating tumor DNA

Event name - ASCO 2017

Catenacci DVT, Green E, Epstein M, Jones G, Morris C, O’Day E, Lomnicki S, Maranto M, Karrison T, Kindler Read More

Liquid biopsies for monitoring brafv600e mutation in advanced brafv600e non-small cell lung cancer (NSCLC)

Event name - WCLC 2017

Laura Mezquita, Cecile Jovelet, Maud Ngocamus, Edouard Auclin, Jordi Remon, Emma Green, Vincent Plagnol, Clive Morris, Anas Gazzah, Caroline Caramella, Julien Adam, Ludovic Lacroix, Luc Friboulet, Jean-Charles Soria, Benjamin Besse, David Planchard Read More

Early detection of competing resistance mutations using plasma next-generation sequencing in patients with EGFR-mutant NSCLC treated with osimertinib

Event name - ASCO 2017

Nicolas M Guibert, Cloud Paweletz, Yuebi Hu, Nora Feeney, Vincent Plagnol, Valerie Poole, Greg Jones, Geoffrey Oxnard Read More

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer

Event name - Annals of Oncology 2017

Charlotte Fribbens, Isaac Garcia Murillas, Matthew Beaney, Sarah Hrebien, Ben O’Leary, Lucy Kilburn, Karen Howarth, Michael Epstein, Emma Green, Nitzan Rosenfeld, Alistair Ring, Stephen Johnston, Nicholas Turner Read More

Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA

Event name - Annals of Oncology 2017

J. Remon, C. Caramella, C. Jovelet, L. Lacroix, A. Lawson, S. Smalley, K. Howarth, D. Gale, E. Green, V. Plagnol, N. Rosenfeld, D. Planchard, M. V. Bluthgen, A. Gazzah, C. Pannet, C. Nicotra, E. Auclin, J. C. Soria and B. Besse Read More

Tracking evolution of aromatase inhibitor resistance with circulating tumor DNA in metastatic breast cancer

Event name - ASCO 2017

Charlotte Fribbens, Isaac Garcia-Murillas, Matthew Beaney, Sarah Hrebien, Karen Howarth, Michael Epstein, Nitzan Rosenfeld, Alistair Ring, Stephen Johnston and Nicholas C. Turner Read More

Analytical performance and validation of an InVision® circulating tumour DNA sequencing assay across two laboratories

Event name - WCLC 2016

Tim Forshew, Andrew Lawson, Sarah Smalley, Vincent Plagnol, John Calaway, Shannon Blais, Karen Howarth, Greg Jones, Michelle Pugh, Mikidache Madi, Bradley Durham, Esther Musgrave-Brown, Samuel Woodhouse, Nitzan Rosenfeld, Davina Gale, Emma Green and James Clark Read More

Evaluation of liquid biopsies for molecular profiling and monitoring in advanced non-small cell lung cancer (NSCLC) patients

Event name - ASCO 2016

Remon J, Soria JC, Lacroix L, Howarth K, Lawson A, Smalley S, Gale D, Plagnol V, Green E, Rosenfeld N, Planchard D, Jovelet C, Pannet C, Besse B Read More

Analytical performance and validation of an enhanced TAm-Seq™ circulating tumour DNA sequencing assay across two laboratories

Event name - NCRI 2016

Karen Howarth, John Calaway, Sarah Smalley, Shannon Blais, Andrew Lawson, Greg Jones, Davina Gale, Michelle Pugh, Mikidache Madi, Bradley Durham, Esther Musgrave-Brown, Samuel Woodhouse, Tim Forshew, Emma Green, Vincent Plagnol, Nitzan Rosenfeld and James Clark Read More

Liquid biopsies for molecular profiling of mutations in non-small cell lung cancer (NSCLC) patients lacking tissue samples

Event name - AACR 2016

Remon J, Soria JC, Planchard D, Jovelet C, Pannet C, Lacroix L, Gazzah A, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Olaussen K, Chaput N, Besse B Read More

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

Event name - PLOS Medicine 2016

Christine A. Parkinson, Davina Gale, Anna Piskorz, Heather Biggs, Charlotte Hodgkin, Helen Addley, Sue Freeman, Penelope Moyle, Evis Sala, Karen Sayal, Karen Hosking, Ioannis Gounaris, Mercedes Jimenez-Linan, Helena M. Earl, Wendi Qian, Nitzan Rosenfeld, James Brenton Research was conducted through CRUK, not Inivata. Read More

Analytical performance and validation of an enhanced TAm-Seq™ circulating tumor DNA sequencing assay

Event name - AACR 2016

Davina Gale, Vincent Plagnol, Andrew Lawson, Michelle Pugh, Sarah Smalley, Karen Howarth, Mikidache Madi, Bradley Durham, Vasudev Kumanduri, Kitty Lo, Peter Dimitrov, Jordi Remon, Benjamin Besse, James Clark, Emma Green, Nitzan Rosenfeld, Tim Forshew Read More

Osimertinib benefit in ctDNA T790Mpositive, EGFR-mutant NSCLC patients

Event name - WCLC 2016

Remon J, Caramella C, Jovelet C, Lacroix L, Lawson A, Smalley S, Howarth K, Gale D, Rosenfeld N, Green E, Plagnol V, Planchard D, Bluthgen MV, Gazzah A, Pannet C, Nicotra C, Soria JC, Besse B Read More

Liquid biopsies for molecular profiling of mutations in non-small cell lung cancer (NSCLC) patients lacking tissue samples

Event name - MAP 2016

Remon J, Soria JC, Planchard D, Jovelet C, Pannet C, Lacroix L, Gazzah A, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Oulassen K, Besse B Read More

Assessing the clinical applications of ctDNA in patients with advanced stage metastatic cancer using our enhanced TAm-Seq™platform

Event name - Molecular Targets and Cancer Therapeutics 2015

Sarah Smalley, Davina Gale, Andrew RJ Lawson, Jordi Remon, Esperanza Perez, Michelle Pugh, Karen D Howarth, Mehdi Touat, Jean-Charles Soria, Antoine Hollebecque, Emma Green, Benjamin Besse, Tim Forshew, Vincent Plagnol, Ludovic Lacroix, Nitzan Rosenfeld Read More

Assessment of clinical applications of circulating tumour DNA in lung cancer using an enhanced TAm-Seq™ platform

Event name - International Association for the Study of Lung Cancer Conference 2015

Davina Gale, Jordi Remon, Andrew RJ Lawson, Sarah Smalley, Esperanza Perez, Karen D Howarth, Michelle Pugh, Abdelaziz Fahem, Tim Forshew, Amanda Bettison, John Beeler, Ludovic Lacroix, Emma Green, Michael Stocum, Vincent Plagnol, Benjamin Besse, Nitzan Rosenfeld Read More

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Event name - Nature 2013 PubMed PMID: 23563269

Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, Bentley D, Chin TM, Brenton JD, Caldas C, Rosenfeld N. Read More

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Event name - N Engl J Med. 2013 PubMed PMID: 23484797

Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, Caldas C, Rosenfeld N. Read More

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Event name - Sci Transl Med. 2012 PubMed PMID: 22649089

Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, Dawson SJ, Piskorz AM, Jimenez-Linan M, Bentley D, Hadfield J, May AP, Caldas C, Brenton JD, Rosenfeld N. Read More

Clinical validation and utility of InVision ctDNA in advanced non-small cell lung cancer (NSCLC) patients

Event name - MAP 2018

Jordi Remon, Laura Mezquita, David Planchard, Cecile Jovelet, Ludovic Lacroix, Etienne Rouleau, Karen Howarth, Vincent Plagnol, Clive Morris, Emma Green, Cecile LePechoux, Caroline Caramella, Julien Adam, Benjamin Besse Read More

Our Technology

Our Solutions

Latest News